112 related articles for article (PubMed ID: 11745437)
1. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis.
Ganguly S; Elbayoumi T
Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038
[TBL] [Abstract][Full Text] [Related]
3. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle studies of cyclocreatine, a new anticancer agent.
Martin KJ; Winslow ER; Kaddurah-Daouk R
Cancer Res; 1994 Oct; 54(19):5160-5. PubMed ID: 7923134
[TBL] [Abstract][Full Text] [Related]
5. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E
Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
Maril N; Degani H; Rushkin E; Sherry AD; Cohn M
Am J Physiol; 1999 Oct; 277(4):C708-16. PubMed ID: 10516101
[TBL] [Abstract][Full Text] [Related]
7. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Kristensen CA; Askenasy N; Jain RK; Koretsky AP
Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
[TBL] [Abstract][Full Text] [Related]
8. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of sarcomeric and ubiquitous mitochondrial creatine kinase is tissue-specific.
Payne RM; Strauss AW
Biochim Biophys Acta; 1994 Sep; 1219(1):33-8. PubMed ID: 8086475
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
Hoosein NM; Martin KJ; Abdul M; Logothetis CJ; Kaddurah-Daouk R
Anticancer Res; 1995; 15(4):1339-42. PubMed ID: 7654018
[TBL] [Abstract][Full Text] [Related]
11. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells.
Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R
J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
Dolder M; Walzel B; Speer O; Schlattner U; Wallimann T
J Biol Chem; 2003 May; 278(20):17760-6. PubMed ID: 12621025
[TBL] [Abstract][Full Text] [Related]
14. Regulation of creatine kinase isoenzymes in human placenta during early, mid-, and late gestation.
Thomure MF; Gast MJ; Srivastava N; Payne RM
J Soc Gynecol Investig; 1996; 3(6):322-7. PubMed ID: 8923416
[TBL] [Abstract][Full Text] [Related]
15. Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine.
Martin KJ; Vassallo CD; Teicher BA; Kaddurah-Daouk R
Anticancer Drugs; 1995 Jun; 6(3):419-26. PubMed ID: 7670140
[TBL] [Abstract][Full Text] [Related]
16. Hearts of some Antarctic fishes lack mitochondrial creatine kinase.
O'Brien KM; Mueller IA; Orczewska JI; Dullen KR; Ortego M
Comp Biochem Physiol A Mol Integr Physiol; 2014 Dec; 178():30-6. PubMed ID: 25151023
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting of tumor cells by the creatine analog cyclocreatine.
Martin K; Winslow E; Okeefe M; Khandekar V; Hamlin A; Lillie J; Kaddurahdaouk R
Int J Oncol; 1996 Nov; 9(5):993-9. PubMed ID: 21541606
[TBL] [Abstract][Full Text] [Related]
18. Expression of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in the fetal rat brain: evidence for a nuclear energy shuttle.
Chen L; Roberts R; Friedman DL
J Comp Neurol; 1995 Dec; 363(3):389-401. PubMed ID: 8847407
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.
Lenz H; Schmidt M; Welge V; Kueper T; Schlattner U; Wallimann T; Elsässer HP; Wittern KP; Wenck H; Staeb F; Blatt T
Mol Cell Biochem; 2007 Dec; 306(1-2):153-62. PubMed ID: 17660950
[TBL] [Abstract][Full Text] [Related]
20. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
